Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients

International Journal of Medical Sciences

Volumn 8, Issue 7, 2011, Pages 540-546

  Dogan, Yuksel ^a   Soylu, Aliye ^a   Eren, Gulay A ^a   Poturoglu, Sule ^b   Dolapcioglu, Can ^c   Sonmez, Kenan ^d   Duman, Habibe ^a   Sevindir, Isa ^a  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c Department of Gastroenterology   (Turkey)

^d KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Inflammatory bowel diseases; Mean platelet volume; P wave dispersion; QT dispersion

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ENTERITIS; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEAN PLATELET VOLUME; P WAVE; PREDICTOR VARIABLE; QT DISPERSION; QT INTERVAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; ULCERATIVE COLITIS;

EID: 80054748390     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.540     Document Type: Article

References (43)

1. Rothfusss KS, Stange EF, Herrlinger KR. Extraintestinal mani-festations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006; 12: 4819-31.
2. Williams H, Walker D, Orchard TR. Extraintestinal manifesta-tions of inflamatory bowel diseases. Curr Gastroenterol. 2008; 10: 597-605.
3. Stasinopoulou P, Kaziani A, Mantzaris G, et al. Paralel mani-festation of Crohn's disease and acute pericarditis: a report of two cases. Int J Colorectal Dis. 2007; 22: 1123-25.
4. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalance of extraintestinal diseases in inflammatory bowel diseaese; a population-based study. Am J Gastroenterol. 2001; 96: 1116-22.
5. Dogru MT, Guneri{dotless} M, Ti{dotless}reli{dotless} E, et al. QT interval and dispersion differences between normal and prehypertensive patients: ef-fects of autonomic and left ventricular functional and structural changes-Original Investigation. The Anatolian Journal of Car-diology. 2009; 9: 15-22.
6. Gunteki{dotless}n U, Gunes Y, Tuncer M, et al. The Effect of Altitude on P-Wave and QT Duration and Dispersion. Pacing Clin Elec-trophysiol. 2008; 31: 889-892.
7. Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006; 47: 362-67.
8. Knorr JP, Moshfeghi M, Sokoloski MC. Ciprofloxacin-induced Q-T interval prolongation. Am J Health Syst Pharm. 2008; 65: 547-51.
9. Kosar F, Aksoy Y, Ari{dotless} F, et al. P-Wave Duration and Dispersion in Obese Subjects. Ann of Noninvasive Electrocardiol. 2008; 13: 3-7.
10. Ozer N, Aytemi{dotless}r K, Atalar E, et al. P wave dispersion in hy-pertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000; 23: 1859-62.
11. Sharma P, Makharia GK, Ahuja V, et al. Autonomic Dysfunc-tions in Patients with Inflammatory Bowel Disease in Clinical Remission. Dig Dis Sci. 2009; 54: 853-61.
12. Coruzzi P, Castiglioni P, Parati G, et al. Autonomic cardiovas-cular regulation in quiescent ulcerative colitis and Crohn's dis-ease. Eur J Clin Invest. 2007; 37: 964-70.
13. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001; 96: 776-81.
14. Danese S, Motte Cd Cde L, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implica-tions. Am J Gastroenterol. 2004; 99: 938-45.
15. Ricart E, Panaccione R, Loftus EV Jr, et al. Autoimmune di-sorders and extraintestinal manifestations in first-degree fami-lial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis. 2004; 10: 207-14.
16. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: Final report on a therapeutic trial. BMJ. 1955; 2: 1041.
17. Best WR, Becktel JM, Singleton JM, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70: 439.
18. Danese S, Semeraro S, Papa A, et al. Extraintestinal manifesta-tions in inflammatory bowel disease. World J Gastroenterol 2005; 11: 7227-36.
19. Novacek G, Haumer M, Schima W, et al. Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literature. Inflamm Bowel Dis. 2004; 10: 430-35.
20. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996; 23: 29-34.
21. Das KM. Relationship of extraintestinal involvements in in-flammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci. 1999; 44: 1-13.
22. Oshitani N, Watanabe K, Nakamura S, et al. Extraintestinal complications in patients with ulcerative colitis. Nippon Rinsho. 2005; 63: 874-78.
23. Mendoza JL, Lana R, Taxonera C, et al. Extraintestinal mani-festations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis. Med Clin (Barc). 2005; 125: 297-300.
24. Bansal D, Chahoud G, Ison K, et al. Pleuropericarditis and pericardial tamponade associated with inflammatory bowel disease. J Ark Med Soc. 2005; 102: 16-9.
25. Dorn SD, and Sandler RS. Inflammatory Bowel Disease i{dotless}s not a ri{dotless}sk factor for cardiovascular disease mortality: Results from a Systematic Review and Meta-Analysis. Am J Gastroenterology. 2007; 102: 662-67.
26. Papa A, Santoliquido A, Danese S, et al. Increased carotid in-tima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005; 22: 839-46.
27. Efremidis M, Prappa E, Kardaras F. Acute myocardial infarc-tion in a young patient during an exacerbation of ulcerative co-litis. Int J Cardiol. 1999; 70: 211-12.
28. Mutlu B, Ermeydan CM, et al. Acute myocardial infarction in a young woman with severe ulcerative colitis. Int J Cardiol 2002; 83: 183-85.
29. Turgut O, Tandogan I, Yilmaz MB, et al. Association of P wave duration and dispersion with the risk for atrial fibrillation: Practical considerations in the setting of coronary artery dis-ease. Int J Cardiol. 2010; 144: 322-24.
30. Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardi-ographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998; 135: 733-38.
31. Dogan SM, Aydi{dotless}n M, Gursurer M, et al. The increase in P-wave dispersion is associated with the duration of disease in patients with Behçet's disease. Int J Cardiol. 2008; 124: 407-10.
32. Guler H, Seyfeli{dotless} E, Sahi{dotless}n G, et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echo-cardiographic parameters. Rheumatol Int 2007; 27: 813-18.
33. Yavuzki{dotless}r M, Ozturk A, Dagli{dotless} N, et al. Effect of ongoing in-flammation in rheumatoid arthritis on P-wave dispersion. J Int Med Res. 2007; 35: 796-802.
34. Uchiyama K, Hayashi K, Fujino N, et al. Impact of QT Variables on Clinical Outcome of Genotyped Hypertrophic Cardiomyo-pathy. Ann Noninvasive Electrocardiol. 2009; 14: 65-71.
35. Gurgun C, Ercan E, Ceyhan C, et al. Cardiovascular involve-ment in Behçet's disease. Jpn Heart J. 2002; 43: 389-98.
36. Ziegler D, Zentai CP, Perz S, et al. KORA Study Group. Predic-tion of mortality using measures of cardiac autonomic dys-function in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care. 2008; 31: 556-61.
37. Psallas M, Tentolouris N, Cokkinos A, et al. QT dispersion: comparison between diabetic and non-diabetic individuals and correlation with cardiac autonomic neuropathy. Hellenic J Cardiol. 2006; 47: 255-62.
38. Yavuz B, Atalar E, Karadag O, et al. QT dispersion increases in patients with systemic lupus erythematosus. Clin Rheumatol. 2007; 26: 376-79.
39. Uyarel H, Uslu N, Okmen E, et al. QT Dispersion in Sarcoidosis. Chest. 2005; 128: 2619-25.
40. Dimopoulos S, Nicosia F, Donati P, et al. QT Dispersion and Left Ventricular Hypertrophy in Elderly Hypertensive and Normotensive Patients. Angiology. 2008; 59: 605-12.
41. Curione M, Aratari A, Amato S, et al. A study on QT interval in patients affected with inflammatory bowel disease without cardiac involvement. Intern Emerg Med. 2010; 5:307-10.
42. Yüksel O, Helvaci K, Başar O, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets. 2009; 20:277-81.
43. Zubcevic N, Mesihovic R, Zubcevic S. Usefulness of laboratory data in estimation of Crohn's disease activity. Med Arh. 2010; 64:33-6.